What are the therapeutic alternatives to dextropropoxyphene in France? A prescribers’ survey - 21/02/17
, E. Chrétien a, L. Letrilliart b, M. Ginoux c, M. Belhassen c, M. Lanteri-Minet d, E. Van Ganse c, e, H. Beloeil fSfar members of pain-ALR committee
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
| pages | 5 |
| Iconographies | 2 |
| Vidéos | 0 |
| Autres | 0 |
Abstract |
About a year after dextropropoxyphene (DXP) withdrawal from the French market, we conducted a survey among members of the French Society of Anesthesia & Intensive Care Medicine (Sfar) and of the French Society of the Study and Treatment of Pain (SFETD) to identify the indications for which this WHO level II analgesic had been prescribed, the prescriber's feedback following withdrawal, and the substitutive analgesics prescribed. DXP had been prescribed by more than 75% of the 430 anaesthesiologists and 230 pain specialists interviewed, mainly for acute and chronic non-cancer pain of moderate intensity. While two thirds of pain specialists were not satisfied with DXP withdrawal, this decision did not affect the majority of anaesthesiologists. In both groups, the main substitutive analgesic was tramadol combined with acetaminophen, while only 24% of prescribers considered acetaminophen alone as a substitute.
Le texte complet de cet article est disponible en PDF.Keywords : Pain, Treatment, Dextropropoxyphene
Plan
Vol 36 - N° 1
P. 15-19 - février 2017 Retour au numéro
Article précédent
- Ultrasonographic diaphragmatic excursion is inaccurate and not better than the MRC score for predicting weaning-failure in mechanically ventilated patients
- Cédric Carrie, Chloé Gisbert-Mora, Eline Bonnardel, Bernard Gauche, Matthieu Biais, Frédéric Vargas, Gilles Hilbert
- Evolution of stress in anaesthesia registrars with repeated simulated courses: An observational study
- Antoine Gouin, Cédric Damm, Grégory Wood, Sébastien Cartier, Marie Borel, Karen Villette-Baron, Sylvain Boet, Vincent Compère, Bertrand Dureuil
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’achat d’article à l’unité est indisponible à l’heure actuelle.
Déjà abonné à cette revue ?